Literature DB >> 18684668

Postgenomic research on leishmaniasis: a critical self-appraisal.

Paul M Kaye1, Jenefer M Blackwell.   

Abstract

Scientific conferences, a major feature of academic life, rarely provide the opportunity for self-appraisal of a research field. During a 2007 meeting on leishmaniasis research in the postgenomic era, approximately 60 researchers participated in group discussions that aimed to provide a critical self-appraisal of the state of the field and to highlight major roadblocks that are likely to prevent the translation of new research into tools for leishmaniasis control. These discussions demonstrated a surprising concordance of views and highlighted several crucial areas for future development.

Entities:  

Mesh:

Year:  2008        PMID: 18684668      PMCID: PMC2817896          DOI: 10.1016/j.pt.2008.06.004

Source DB:  PubMed          Journal:  Trends Parasitol        ISSN: 1471-4922


  33 in total

Review 1.  Organ-specific immune responses associated with infectious disease.

Authors:  C R Engwerda; P M Kaye
Journal:  Immunol Today       Date:  2000-02

2.  The economic burden of Kala-azar in households of the Danusha and Mahottari districts of Nepal.

Authors:  Shiva Raj Adhikari; Nephi Matangi Maskay
Journal:  Acta Trop       Date:  2003-09       Impact factor: 3.112

Review 3.  The immunology of susceptibility and resistance to Leishmania major in mice.

Authors:  David Sacks; Nancy Noben-Trauth
Journal:  Nat Rev Immunol       Date:  2002-11       Impact factor: 53.106

Review 4.  Molecular aspects of parasite-vector and vector-host interactions in leishmaniasis.

Authors:  D Sacks; S Kamhawi
Journal:  Annu Rev Microbiol       Date:  2001       Impact factor: 15.500

5.  The genome sequence of Trypanosoma cruzi, etiologic agent of Chagas disease.

Authors:  Najib M El-Sayed; Peter J Myler; Daniella C Bartholomeu; Daniel Nilsson; Gautam Aggarwal; Anh-Nhi Tran; Elodie Ghedin; Elizabeth A Worthey; Arthur L Delcher; Gaëlle Blandin; Scott J Westenberger; Elisabet Caler; Gustavo C Cerqueira; Carole Branche; Brian Haas; Atashi Anupama; Erik Arner; Lena Aslund; Philip Attipoe; Esteban Bontempi; Frédéric Bringaud; Peter Burton; Eithon Cadag; David A Campbell; Mark Carrington; Jonathan Crabtree; Hamid Darban; Jose Franco da Silveira; Pieter de Jong; Kimberly Edwards; Paul T Englund; Gholam Fazelina; Tamara Feldblyum; Marcela Ferella; Alberto Carlos Frasch; Keith Gull; David Horn; Lihua Hou; Yiting Huang; Ellen Kindlund; Michele Klingbeil; Sindy Kluge; Hean Koo; Daniela Lacerda; Mariano J Levin; Hernan Lorenzi; Tin Louie; Carlos Renato Machado; Richard McCulloch; Alan McKenna; Yumi Mizuno; Jeremy C Mottram; Siri Nelson; Stephen Ochaya; Kazutoyo Osoegawa; Grace Pai; Marilyn Parsons; Martin Pentony; Ulf Pettersson; Mihai Pop; Jose Luis Ramirez; Joel Rinta; Laura Robertson; Steven L Salzberg; Daniel O Sanchez; Amber Seyler; Reuben Sharma; Jyoti Shetty; Anjana J Simpson; Ellen Sisk; Martti T Tammi; Rick Tarleton; Santuza Teixeira; Susan Van Aken; Christy Vogt; Pauline N Ward; Bill Wickstead; Jennifer Wortman; Owen White; Claire M Fraser; Kenneth D Stuart; Björn Andersson
Journal:  Science       Date:  2005-07-15       Impact factor: 47.728

6.  CD8+ T cells are required for primary immunity in C57BL/6 mice following low-dose, intradermal challenge with Leishmania major.

Authors:  Yasmine Belkaid; Esther Von Stebut; Susana Mendez; Rosalia Lira; Elisabet Caler; Sylvie Bertholet; Mark C Udey; David Sacks
Journal:  J Immunol       Date:  2002-04-15       Impact factor: 5.422

7.  Genetic susceptibility to visceral leishmaniasis in The Sudan: linkage and association with IL4 and IFNGR1.

Authors:  H S Mohamed; M E Ibrahim; E N Miller; C S Peacock; E A G Khalil; H J Cordell; J M M Howson; A M El Hassan; R E H Bereir; J M Blackwell
Journal:  Genes Immun       Date:  2003-07       Impact factor: 2.676

8.  How better drugs could change kala-azar control. Lessons from a cost-effectiveness analysis.

Authors:  M Boelaert; D Le Ray; P Van Der Stuyft
Journal:  Trop Med Int Health       Date:  2002-11       Impact factor: 2.622

9.  SLC11A1 (formerly NRAMP1) and susceptibility to visceral leishmaniasis in The Sudan.

Authors:  Hiba Salah Mohamed; Muntaser Eltayeb Ibrahim; Elinor Nancy Miller; Jacqueline Katie White; Heather Jane Cordell; Joanna McCammond McGill Howson; Christopher Sean Peacock; Eltahir Awad Gasim Khalil; Ahmed Mohamed El Hassan; Jenefer Mary Blackwell
Journal:  Eur J Hum Genet       Date:  2004-01       Impact factor: 4.246

10.  Toward a defined anti-Leishmania vaccine targeting vector antigens: characterization of a protective salivary protein.

Authors:  J G Valenzuela; Y Belkaid; M K Garfield; S Mendez; S Kamhawi; E D Rowton; D L Sacks; J M Ribeiro
Journal:  J Exp Med       Date:  2001-08-06       Impact factor: 14.307

View more
  1 in total

Review 1.  Leishmaniasis: complexity at the host-pathogen interface.

Authors:  Paul Kaye; Phillip Scott
Journal:  Nat Rev Microbiol       Date:  2011-07-11       Impact factor: 60.633

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.